|
NEWS, EVENTS, and DEADLINES
November 6, 2024
| |
From left: Jonathan Holloway, President, Rutgers University; Mark Manigan, CEO, RWJBarnabas Health; Brian Strom, Chancellor, Rutgers Health; Governor Phil Murphy; Shawna Hudson, Vice Chancellor for Translational Medicine and Science Director, Rutgers Health; Reynold Panettieri, Vice Chancellor for Translational Medicine and Science, Rutgers Health. Photo: Luca Mostello | |
Clinical and Translational Science Award (CTSA) Renewal Celebration
New Jersey Governor Phil Murphy joined NJ ACTS and community leaders on October 30th to celebrate the renewal the CTSA.
Read the full article
| |
|
Shawna Hudson Elected to the National Academy of Medicine
For more than two decades, Shawna Hudson has been making inroads – through research and work in the community – to improve the health of underserved populations. This week, the Rutgers Health medical sociologist joins the ranks of 100 new members invited to join the National Academy of Medicine. Considered one of the highest honors in the fields of health and medicine, membership in the academy recognizes individuals who have made major contributions to the advancement of the medical sciences, health care and public health. Read the full article
Dr. Hudson, Vice Chancellor for Dissemination and Implementation Science for Rutgers Health, is the Associate Director of NJ ACTS.
| |
|
Princeton-Rutgers Collaboration Awarded $16M Research Grant to Advance Understanding of Mental Illness
A Princeton-led collaboration with Rutgers has been awarded a $16 million federal grant to enhance the understanding of mental health disorders through the lens of computational psychiatry. Spearheaded by Princeton neuroscience and psychology professor Yael Niv, PhD, the five-year Conte center grant funded by the National Institute of Mental Health aims to explore how different disorders like depression, anxiety, and substance use disorder may be affected by differences in latent cause inference. Read the Full article from the Princeton Neuroscience Institute
In addition to Dr. Niv, Princeton's Jonathan Cohen, MD, PhD and Nathaniel Daw, PhD, who were Co-Leads of the previous CTSA grant's NJ ACTS Machine Learning Core, are part of the team of investigators for this new grant. Dr. Cohen was also an NJ ACTS 2020 Pilot Program awardee.
| |
Upcoming NJ ACTS, Rutgers, Princeton and NJIT Events | |
|
Princeton Precision Health
2024 Seminar Series
Princeton Precision Health is a cross-cutting initiative that uses AI and data science to transform human health at all levels, from molecular to social to environmental, with the goal of enacting smart policy and evidence-based clinical practice.
| |
|
Data-Driven Precision Health: Integrating Genomics, Climate, and the Environment
November 7, 2024
8 am - 5:30 pm
in person
Maeder Hall, Andlinger Center
86 Olden Street
Princeton University
| |  |
|
Talking tech: How parents and kids co-create social norms about technology use
Emily Foster-Hanson, PhD
Department of Psychology, Swarthmore College
November 15, 2024
12 pm - 1 pm
in person
252 Nassau Street
Princeton, NJ
| | |
|
Propelus I-Corps is a program designed for research teams with a technology innovation to explore how their discovery can help potential customers and meet industry needs as a startup or venture.
Propelus I-Corps hosted by Princeton University
| |
|
Online
January 8, 10, 17 and 24
9:30 am - 12:30 pm
Apply by Dec. 5
| | |
|
|
|
What to Expect When Engaging with
Biostatistics and Epidemiology Consultants
Rutgers University Biostatistics & Epidemiology Services (RUBIES) is the “action arm” of the BERD core within NJACTS, primarily responsible for facilitating the translation of science into practice by providing easily accessible advanced clinical study design and data analysis support.
If you are at the early stages of study design, have already collected data and are unsure how to analyze it, or need help drafting your manuscript, the RUBIES team is here to help. See our guide, including recommendations for engaging with RUBIES to ensure our collaboration is productive and successful!
Ready to work with RUBIES? We offer a complimentary 1-hour initial consultation for all new project requests.
Questions? Contact the RUBIES Project Manager, Natale Mazzaferro, at natale.mazzaferro@rutgers.edu. Ask us about our Canvas page, where we house our biostatistics and epidemiology workshops!
| | | |
NCATS, NIH, and Federal News and Events | |
Collaboration Webinars from the
Hear from CTSA TIN experts on trial-related topics to improve your project
| |
|
Adaptive Clinical Trial Designs: From Basics to Bayesian
As resources become increasingly limited, adaptive clinical trial designs have been proposed to conduct more efficient translational research. These designs include elements to stop trials before completion for futility, efficacy, or safety; adapt the allocation across study arms; enrich the population enrolled; revise target sample sizes; or to add/drop study arms.
November 20, 2024
12 pm
| |
Important Update - Human Subjects | |
|
World Medical Association Declaration of Helsinki
Ethical Principles for Medical Research Involving Human Participants
The World Medical Association (WMA) Declaration of Helsinki is a set of ethical principles for medical research that involves human participants. The Declaration is not a legal document, but it is the most influential code of ethics for medical research. The WMA released its latest revision on October 19, 2024.
| |
Rutgers Gardens is a 180-acre public garden with a student farm, farmer's market, bamboo forest, and more. | |
The New Jersey Kids Study has just launched its pilot study to assess exposures that affect children's health. They hope to enroll pregnant people in their first trimester in this IRB-approved study. | |
NJ ACTS is a partnership between Rutgers, NJIT and Princeton. NJ ACTS advances clinical and translational science to develop new therapies and treatments and improve population health.
| |
|
This newsletter is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number, UM1TR004789 to Rutgers University. The content is solely the responsibility of the authors and does not represent the official views of the NIH.
New Jersey Alliance for Clinical and Translational Science
89 French St., Suite 4211
New Brunswick, NJ
Copyright 2020 New Jersey Alliance for Clinical and Translational Science, all rights reserved
Send story ideas to NJACTS@rbhs.rutgers.edu
UL1TR003017 (pre-5/1/2024), UM1TR004789 (starting 5/1/2024), KL2TR003018 and TL1TR003019
| | | | |
